首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

市場調查報告書

商品編碼

1741497

桿狀病毒表達系統市場按產品類型、應用、最終用戶和地區分類

Baculovirus Expression System Market, By Product Type, By Application, By End User, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

桿狀病毒表現系統市場規模預計在 2025 年為 4.36 億美元，預計到 2032 年將達到 7.818 億美元，2025 年至 2032 年的複合年成長率為 8.7%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	4.36億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	8.70%	2032年價值預測	7.818億美元

桿狀病毒表現系統是一種用途廣泛、在生物技術領域用於重組蛋白質生產的工具。桿狀病毒是一種能夠感染昆蟲細胞並被改造以表達目的外源基因的昆蟲病毒。與其他表現系統相比，此表現系統具有許多優勢，包括高蛋白產量、轉譯後修飾以及可擴展性。

桿狀病毒表現系統可應用於生物製藥生產、蛋白質研究、疫苗開發、基因治療等各領域。多年來，該系統經過廣泛的研究和最佳化，變得更加高效和通用。

市場動態：

預計未來幾年全球桿狀病毒表現系統市場將顯著成長。這一成長受多種因素驅動，包括用於治療和研究的重組蛋白需求的不斷成長。桿狀病毒表達系統因其能夠生產大量複雜且功能性的蛋白質而受到生物製藥行業的青睞。

推動市場發展的另一個因素是，用於開發新型治療方法和疫苗的研發活動的投資不斷增加。桿狀病毒表現系統為此類生技藥品的生產提供了一個可靠且經濟高效的平台。

然而，市場也存在一些限制因素。主要挑戰之一是使用桿狀病毒表達系統的蛋白質生產過程複雜且耗時。最佳化和擴大系統需要技術專長，並且需要大量勞動力。

然而，市場中存在著巨大的成長機會。個人化醫療和先進療法的日益成長的關注，催生了對客製化蛋白質生產系統的需求。桿狀病毒表現系統憑藉其靈活性和生產多種蛋白質的能力，可以滿足這項需求。

本研究的主要特點

本報告對全球桿狀病毒表現系統市場進行了詳細分析，包括預測期 2025-2032 的市場規模和複合年成長率（以 2024 年為基準年）。
它揭示了不同領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
介紹了全球桿狀病毒表達系統市場的主要企業，包括公司亮點、產品系列、關鍵亮點、績效和策略。
研究涉及的主要企業包括賽默飛世爾科技、默克公司、Takara Bio、安捷倫科技、Oxford Expression Technologies、Promega Corporation、Qiagen NV、Bio-Rad Laboratories、New England Biolabs、Genscript Biotech Corporation、Syngene International Limited、Sartorius AG、Aragenbody Biolabs、VivgeneureCan、Sartorids、Abutesan Biocan Bioscience、Vivopure、Crantives、Abdeal、Abute、Camph、Camph、Cranative、Crantives、Acgenbody） Inc.、Proteogenix 和 Virovek。
本報告的見解將使負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
全球桿狀病毒表達系統市場報告針對行業中的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將受益於用於分析全球桿狀病毒表達系統市場的策略矩陣，從而更容易做出決策。

Thermo Fisher Scientific
Merck KGaA
Takara Bio
Agilent Technologies
Oxford Expression Technologies
Promega Corporation
Qiagen NV
Bio-Rad Laboratories
New England Biolabs
Genscript Biotech Corporation
Syngene International Limited
Sartorius AG
Aragen Bioscience
Vivopure
Creative Biogene
Absolute Antibody
Rockland Immunochemicals
Protein Technologies, Inc.（PTI）
Proteogenix
Virovek

第 10 章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI6360

Baculovirus Expression System Market is estimated to be valued at USD 436.0 Mn in 2025 and is expected to reach USD 781.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 436.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.70%	2032 Value Projection:	USD 781.8 Mn

A baculovirus expression system is a highly versatile and widely utilized tool in biotechnology for the production of recombinant proteins. Baculovirus is an insect virus that infects insect cells, and they have been engineered to express foreign genes of interest. This system offers several advantages over other expression systems including high protein yields, post-translational modifications, and scalability.

The baculovirus expression system has found applications in various fields such as biopharmaceutical production, protein research, vaccine development, and gene therapy. The system has been extensively studied and optimized over the years, leading to improved efficiency and versatility.

Market Dynamics:

The global baculovirus expression system market is expected to witness significant growth in the coming years. Several factors are driving this growth, including the increasing demand for recombinant proteins for therapeutic and research purposes. The system's ability to produce high levels of complex and functional proteins has made it a preferred choice in the biopharmaceutical industry.

Another driver of the market is the rising investments in research and development activities for the development of novel therapies and vaccines. The baculovirus expression system provides a reliable and cost-effective platform for the production of these biologics.

However, the market also faces certain restraints. One of the major challenges is the complex and time-consuming process of protein production using the baculovirus expression system. The optimization and scaling-up of the system requires technical expertise and can be labor-intensive.

Nevertheless, the market presents numerous opportunities for growth. The increasing focus on personalized medicine and the development of advanced therapeutics creates a demand for customized protein production systems. The baculovirus expression system, with its flexibility and ability to produce a wide range of proteins, is well-positioned to meet this demand.

Key Features of the Study:

This report provides an in-depth analysis of the global baculovirus expression system market including market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, with 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
Key players in the global baculovirus expression system market are profiled including company highlights, product portfolios, key highlights, financial performance, and strategies
The key companies covered in this study include Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, and Virovek
Insights from this report would enable marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics
The global baculovirus expression system market report caters to various stakeholders in the industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would benefit from the strategy matrices used in analyzing the global baculovirus expression system market, making decision-making easier

Global Baculovirus Expression System Market Segmentation:

By Product Type
- Baculovirus
- Expression Vector
- Reagents
- Others
By Application
- Therapeutics
- Vaccines
- Protein Purification
- Others
By End User
- Biopharmaceutical Companies
- Research Institutes
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Thermo Fisher Scientific
- Merck KGaA
- Takara Bio
- Agilent Technologies
- Oxford Expression Technologies
- Promega Corporation
- Qiagen N.V.
- Bio-Rad Laboratories
- New England Biolabs
- Genscript Biotech Corporation
- Syngene International Limited
- Sartorius AG
- Aragen Bioscience
- Vivopure
- Creative Biogene
- Absolute Antibody
- Rockland Immunochemicals
- Protein Technologies, Inc. (PTI)
- Proteogenix
- Virovek

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Baculovirus Expression System Market, By Product Type
- Global Baculovirus Expression System Market, By Application
- Global Baculovirus Expression System Market , By End User
- Global Baculovirus Expression System Market , By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
The increasing demand for recombinant proteins for therapeutic and research purposes
- Restraints
The complex and time-consuming process of protein production
- Opportunities
The increasing focus on personalized medicine and the development of advanced therapeutics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Baculovirus Expression System Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Baculovirus Expression System Market, By Product Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Baculovirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Expression Vector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Baculovirus Expression System Market, By Application, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Protein Purification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Baculovirus Expression System Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Baculovirus Expression System Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 -2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 -2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 -2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032,(US$ Mn)
  - U.S
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 -2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 -2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 -2032,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
  - U.K
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 -2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 -2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 -2032,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2020 - 2032, (US$ Mn)
  - GCC
  - IsraelNorth Africa
  - Central Africa
  - South Africa
  - Rest of Middle East & Africa

9. Competitive Landscape

Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takara Bio
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Oxford Expression Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Promega Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Qiagen N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
New England Biolabs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Genscript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Syngene International Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sartorius AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Aragen Bioscience
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Vivopure
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Creative Biogene
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Absolute Antibody
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Rockland Immunochemicals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Protein Technologies, Inc. (PTI)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Proteogenix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Virovek
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views